Zobrazeno 1 - 10
of 240
pro vyhledávání: '"Sk, Anderson"'
Autor:
Monica M. Reinholz, E. A. Perez, Julie Gralow, Amylou C. Dueck, EP Winer, Jin Jen, Karla V. Ballman, Jeanette E. Eckel-Passow, SK Anderson, Yan W. Asmann, Robert B. Jenkins, Wilma L. Lingle, GW Sledge, EA Thompson
Publikováno v:
Cancer Research. 72:PD10-04
Background: Adding adjuvant trastuzumab to chemotherapy for patients (pts) with resected HER2+ breast cancer (BC) improves disease free and overall survival (Perez EA, et al. J Clin Oncol 2011). Understanding which pts are most likely to benefit from
Autor:
JM Lumsden, Sergey Ivanov, Jerrold M. Ward, SK Anderson, N Morris, Alla V. Ivanova, L Tessarolo, V Pascal, Michael I. Lerman
Publikováno v:
The Journal of pathologyReferences. 211(5)
The Fus1 gene resides in the critical 3p21.3 human chromosomal region deleted in lung and breast cancers. Recently, the tumour suppressor properties of Fus1 were confirmed experimentally by intra-tumoural administration of Fus1 that suppressed experi
Autor:
Jr, Ortaldo, Winkler-Pickett R, Willette-Brown J, Rl, Wange, Sk, Anderson, Gj, Palumbo, Lh, Mason, Daniel McVicar
Publikováno v:
Europe PubMed Central
Murine NK cells express Ly-49 family receptors capable of either inhibiting or activating lytic function. The overlapping patterns of expression of the various receptors have complicated their precise biochemical characterization. Here we describe th
Autor:
Ap, Makrigiannis, Gosselin P, Lh, Mason, Ls, Taylor, Daniel McVicar, Jr, Ortaldo, Sk, Anderson
Publikováno v:
Europe PubMed Central
The majority of the known Ly49 family members have been isolated from either C57BL/6 (B6) or BALB/c mice. Interestingly, the anti-Ly49 Ab reactivities observed in 129/J mice are different from those of B6 mice. Furthermore, immunoprecipitation of 129
Publikováno v:
Europe PubMed Central
The endocytosis and degradation of 125I-labeled anti-mu monoclonal antibody DA4-4 by a Burkitt's lymphoma cell line was investigated using biochemical, chromatographic, electrophoretic, radioautographic, and electron microscopic techniques. 125I-DA4-
Publikováno v:
Europe PubMed Central
The HER-2/neu oncogene encodes a Mr 185,000 transmembrane phosphoglycoprotein which is overexpressed in 25-35% of breast and ovarian neoplasms and portends a poor prognosis. We have studied the feasibility of targeting this oncoprotein, designated p1
Publikováno v:
Europe PubMed Central
Seven murine monoclonal antibodies (MoAbs) recognizing differentiation antigens present on B-lymphocytes were analyzed in preclinical studies for their potential use for antibody-targeted therapy of B-cell malignancies. MoAbs HD37 (anti-CD19), 1F5 (a
Publikováno v:
Europe PubMed Central
The rates of degradation of radioiodinated monoclonal antibodies (MoAbs) by malignant T- and B-lymphoid cells were studied in the presence and absence of a variety of pharmacological agents known to affect the intracellular metabolism of internalized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::121c2ce6c93d3a624735c1ca45b1219e
http://europepmc.org/abstract/med/2297772
http://europepmc.org/abstract/med/2297772
Publikováno v:
Europe PubMed Central
Killer cell inhibitory receptors represent a family of p58/70-Ig-like proteins expressed on the surface of human NK cells. Engagement of class I MHC by killer cell inhibitory receptors turns off the lytic machinery of NK cells. This receptor/ligand i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7e4abccd9a225f566c56a8e95530f896
http://europepmc.org/abstract/med/9379012
http://europepmc.org/abstract/med/9379012
Autor:
Lh, Mason, Willette-Brown J, Sk, Anderson, Gosselin P, Ew, Shores, Pe, Love, Jr, Ortaldo, Daniel McVicar
Publikováno v:
Europe PubMed Central
Ly-49D is an activating receptor on NK cells that does not become tyrosine phosphorylated upon activation. This report demonstrates that immunoprecipitation of Ly-49D, following pervanadate treatment or specific Ab cross-linking, coprecipitates a 16-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3c8d194d73950ecc4367550c0320317b
http://europepmc.org/abstract/med/9574512
http://europepmc.org/abstract/med/9574512